THD Versus Open Haemorrhoidectomy
Launched by HOLBAEK SYGEHUS · Feb 11, 2014
Trial Information
Current as of May 19, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The patient has Grade III-IV haemorrhoids or Grade II haemorrhoids with bleeding resistant to rubber band ligation or sclerotherapy
- • The patient has a Haemorrhoidal Symptom Score of 4 or more
- • The patient has an American Society of Anaesthesiologists (ASA) score I-II
- • The patient's age is 18-85 years at inclusion
- • The patient has had a colonoscopy, sigmoidoscopy or rigid rectoscopy within 3 months before inclusion
- Exclusion Criteria:
- • The patient has had previous operation for haemorrhoids within the last 2 years
- • The patient has had previous operation for anal incontinence
- • The patient has an active anal fistula
- • The patient has an active anal fissure
- • The patient has anal incontinence for solid stools
About Holbaek Sygehus
Holbæk Sygehus, a leading healthcare institution in Denmark, is dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a strong emphasis on collaboration and ethical practice, the hospital provides a robust infrastructure for conducting a diverse range of studies across various therapeutic areas. Holbæk Sygehus is committed to fostering a patient-centered approach, ensuring that clinical trials not only contribute to scientific knowledge but also prioritize safety and well-being. Through its experienced research team and state-of-the-art facilities, Holbæk Sygehus plays a pivotal role in the development of new therapies and enhancements in clinical care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Holbaek, , Denmark
Patients applied
Trial Officials
Gunnar Olaison, MD, Ph.D
Principal Investigator
Departement of Surgery, Holbaek County Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials